Stephanie Lynn Sorensen
Directeur Financier/CFO chez MEDIZONE INTERNATIONAL, INC.
Profil
Stephanie Lynn Sorensen is currently the Chief Financial Officer at Medizone International, Inc. and the Financial Controller at UpStart Ventures LLC.
Previously, she worked as an Assistant Controller at World Heart Corp.
and SINTX Technologies, Inc. She also served as a Controller at Q Therapeutics, Inc. and Elute, Inc. Sorensen holds a Master's in Business Administration from the University of Utah and an undergraduate degree from Brigham Young University.
Postes actifs de Stephanie Lynn Sorensen
| Sociétés | Poste | Début |
|---|---|---|
| MEDIZONE INTERNATIONAL, INC. | Directeur Financier/CFO | 01/10/2016 |
Upstart Ventures LLC
 Upstart Ventures LLC Investment ManagersFinance UpStart Ventures LLC (UpStart Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Salt Lake City, Utah. | Private Equity Investor | 01/05/2012 |
Anciens postes connus de Stephanie Lynn Sorensen
| Sociétés | Poste | Fin |
|---|---|---|
World Heart Corp.
 World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Comptroller/Controller/Auditor | 30/08/2012 |
World Heart Corp.
World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | 01/08/2012 |
| SINTX TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/10/2009 |
Elute, Inc.
 Elute, Inc. Medical SpecialtiesHealth Technology Elute, Inc. develops polymer controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. The company was founded by David W. Grainger and Dennis B. Farrar in 2010 and is headquartered in Salt Lake City, UT. | Comptroller/Controller/Auditor | - |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Comptroller/Controller/Auditor | - |
Formation de Stephanie Lynn Sorensen
| University of Utah | Masters Business Admin |
| Brigham Young University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SINTX TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Medizone International, Inc.
 Medizone International, Inc. Medical SpecialtiesHealth Technology Medizone International, Inc. engages in the development and commercialization of AsepticSure system and provides disinfection solutions. AsepticSure system provides means of disinfecting non-porous surfaces in hospitals, healthcare facilities and other non- hospital facilities. It operates under the AsepticSure and Trioxidane brands. The company was founded in January 1986 and is headquartered in Kalamazoo, MI. | Health Technology |
World Heart Corp.
World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Commercial Services |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Upstart Ventures LLC
Upstart Ventures LLC Investment ManagersFinance UpStart Ventures LLC (UpStart Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Salt Lake City, Utah. | Finance |
Elute, Inc.
Elute, Inc. Medical SpecialtiesHealth Technology Elute, Inc. develops polymer controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. The company was founded by David W. Grainger and Dennis B. Farrar in 2010 and is headquartered in Salt Lake City, UT. | Health Technology |
